A.D.A.M.
A.D.A.M. is a biotech company that targets artificial bones and tissues market, using it proprietary 3D printing technology. A.D.A.M. focuses on 3D printing of different tissues (initially bones) made of patented organic materials, which can be scala.
A.D.A.M. (Advanced Development of Additive Manufacturing) is a biotechnology startup developing an infrastructure for on-demand, personalized 3D-printed bone implants. The company was co-founded in 2018 by Denys Gurak and Vladimir Usov, stemming from the realization that the 3D printing technology used by the Odesa-based startup Kwambio could be applied to healthcare. A.D.A.M. started as a spin-off from Kwambio but is now a fully independent company headquartered in the United States, with its research and development office remaining in Ukraine.
Denys Gurak, the CEO, brings extensive experience in regulatory affairs, having worked to implement European legislation for medical devices in Ukraine. This background provided him with the necessary expertise to navigate the complexities of bringing a bioprinting product to market. His vision is to create an on-demand, personalized tissue manufacturing platform, starting with bone implants, to reduce barriers to medical treatment. The company has achieved significant milestones, including winning the Startup World Cup Ukraine in 2023 and being accepted into the Elementa Labs virtual incubator program of the Mount Sinai Health System in 2022.
The company's core business revolves around a 'Technology-as-a-Service' (TaaS) model, providing hospitals with a complete Point-of-Care Medical Device Production System (POC MDPS). This system enables medical professionals to manage the entire implant process, from 3D modeling based on patient CT and MRI scans to receiving a sterilized, personalized device ready for implantation. A.D.A.M.'s digital platform allows for the secure storage of imaging data and the creation of 3D implant models. The production time for an implant is up to 24 hours. The technology utilizes two main types of materials: a modified, resorbable biopolymer for tubular bone implants and a ceramic bio-glass for flat bone implants. These materials are designed to be absorbed by the body as new bone grows, potentially reducing the need for follow-up surgeries. The implants have undergone biomechanical testing at institutions like Yale University and the University of Connecticut. The company's products are subject to the FDA's 510(k) clearance pathway, a simplified market approval process.
Keywords: 3D bioprinting, bone implants, personalized medicine, additive manufacturing, medical devices, regenerative medicine, tissue engineering, MedTech, orthopedic implants, custom implants, resorbable biopolymer, ceramic bio-glass, point-of-care manufacturing, surgical planning, medical imaging, CT scans, MRI data, technology-as-a-service, reconstructive surgery, biomedical engineering, Denys Gurak